Articles
Cosmo Pharmaceuticals has announced impressive topline results from its two pivotal Phase 3 trials evaluating clascoterone 5% topical solution for male androgenic alopecia (AGA). These data mark what may be the first major therapeutic breakthrough for male-pattern hair loss in over 30 years. What is Clascoterone? Clascoterone is a topical androgen receptor inhibitor designed to…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Oral finasteride remains one of the most proven treatments for male pattern hair loss, backed by decades of data showing steady improvement in hair density and prevention of further thinning. However, dramatic transformation photos online can create unrealistic expectations.…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Millions of individuals worldwide are estimated to suffer from androgenetic alopecia, which becomes increasingly common with age. Among popular DHT-blocking treatments, topical dutasteride is considered the most potent, providing dual enzyme inhibition for superior effectiveness compared to finasteride. The…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Testosterone replacement therapy (TRT) can be a breakthrough for men with low testosterone levels. It has been shown to boost vitality, sexual function, muscle mass, and energy levels once lost to hormonal decline. However, this life-changing intervention is often…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. In recent years, topical dutasteride has captured increasing attention among people seeking alternatives to standard oral therapies, often due to intolerance or limited results. This surge is fueled by social media testimonials and before-and-after photos that highlight dramatic transformations.…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Topical finasteride has emerged as a highly discussed alternative to oral therapy for androgenic alopecia (AGA). Its growing popularity stems from an appealing hope: local dihydrotestosterone (DHT) suppression directly at the scalp while reducing systemic exposure and associated side…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Many Follicle Thought readers will have likely tried or are taking different pharmaceutical treatments for hair loss. Some might be disappointed by the regrowth achieved, and others may have responded exceptionally well, seeing dramatic results in a short period…
Veradermics, a clinical-stage dermatology company, announced on October 16 the completion of an oversubscribed $150 million Series C financing round. The funding will support the advancement of its lead investigational candidate, VDPHL01—an extended-release oral formulation of minoxidil being studied for androgenic alopecia in both men and women. The company describes it as the first oral…
A new contender in the dermatology field is GeneSkin, an mRNA-based platform developed at Harvard’s Wyss Institute, which aims to address some of the unmet needs in skin and hair health. The minds behind GeneSkin include geneticist George Church and his team, who have been studying which genes help skin and hair stay healthy. By…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Continuing our new approach, here is our complete guide to topical finasteride dosing. Top 3 Recommended Topical Finasteride Brands #1 Ulo (Editor’s Choice) #2 Hims #3 Keeps In this article, we’ll discuss the available clinical literature and how varying…